Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1 - Infected individuals

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 4 SUPPL., 1999, Pages

  Jacobson, Lisa P ^a   Yamashita, Traci E ^a   Detels, Roger ^b   Margolick, Joseph B ^a   Chmiel, Joan S ^c   Kingsley, Lawrence A ^d   Melnick, Sandra ^e   Muñoz, Alvaro ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Effectiveness; Incidence; Kaposi's sarcoma; Non Hodgkin's lymphoma; Potent antiretroviral therapy

Indexed keywords

DELAVIRDINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

AIDS RELATED COMPLEX; ANTIVIRAL ACTIVITY; CANCER INCIDENCE; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG POTENCY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BISEXUALITY; COHORT STUDIES; DRUG THERAPY, COMBINATION; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MULTICENTER STUDIES; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033178438     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. U.S. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1994;6:18
2. Muñoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993;137:423-38.
3. Reynolds P, Saunders LD, Layefsky ME, et al. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137: 19-30.
4. Detels R, Muñoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV-infected duration. JAMA 1998;280:1497-1503.
5. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 1997;315:1194-9.
6. Hogg RS, O'Saughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997;349:1294.
7. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
8. Muñoz A, Hoover DR. Use of cohort studies for evaluating AIDS therapies. In Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. New York: Wiley-Liss, 1995:423-46.
9. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126(2):310-8.
10. Chmiel JS, Detels R, Kaslow RA, et al. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 1987;126:568-77.
11. Detels R, Phair JP, Saah AJ, et al. Recent scientific contributions to understanding HTV/AIDS from the Multicenter AIDS Cohort Study. J Epidemiol (Japan) 1992;2:S11-9
12. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
13. U.S. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-18.
14. U.S. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998;47(RR-5):1-82.
15. Lebbé C, Blum L, Pellet C, et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 1998;12:F45-9
16. Muñoz A, Xu J. Models for the incubation of AIDS and variations according to age and period. Stat Med 1996;15:2459-73.
17. Enger C, Graham N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996;25:1329-34.
18. Martinez-Maza O, Wiegersma S, van der Meijden M, et al. Immune dysfunction and the pathogenesis of AIDS-associated nonHodgkin's lymphoma. Mem Inst Oswaldo Cruz 1998;93:373-81.
19. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
20. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
21. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among American, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-8.
22. Smith MS, Bloomer C, Horvat R, et al. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997;176:84-93.
23. Sturzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997;72:68-71.
24. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HTV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
25. Rizzieri DA, Liu J, Traweek ST, et al. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor. Lancet 1997;349:775-6.
26. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcomaassociated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996;10:175-80.
27. Miles SA. Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol 1994;6:497-502.
28. Cheung TW, Siegal FP. AIDS-related cancer. In Murphy GP, Lawrence L Jr, Lenhard RE Jr, eds. American Cancer Society Textbook of Clinical Oncology. Atlanta: The American Cancer Society, 1995:619-34.
29. Biemer JJ. Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 1990;20:175-91.
30. MacMahon EME, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969-73.